What is MBX Biosciences, Inc.'s operating lease liabilities?

MBX Biosciences, Inc. (MBX) reported operating lease liabilities of $377K in Q1 2026.

What is the long-term trend for MBX Biosciences, Inc.'s operating lease liabilities?

Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s operating lease liabilities has grown at a 57.5% compound annual growth rate (CAGR), from $171K to $424K.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

MBX Biosciences, Inc. MBX Operating Lease Liabilities

Operating Lease Liabilities at other companies

Amylyx Pharmaceuticals, Inc.AMLX

$4.48M+1,269%

BridgeBio PharmaBBIO

$14.22M+189%

Nurix Therapeutics, Inc.NRIX

$55.45M+177%

Crinetics PharmaceuticalsCRNX

$41.32M-6.0%

XER

Xeris Biopharma Holdings, Inc.XERS

$31.06M-5.5%

Opko HealthOPK

$35.64M-7.1%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.3B+475%

Enterprise value$2.26B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s operating lease liabilities?: MBX Biosciences, Inc. (MBX) reported operating lease liabilities of $377K in Q1 2026.
What is the long-term trend for MBX Biosciences, Inc.'s operating lease liabilities?: Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s operating lease liabilities has grown at a 57.5% compound annual growth rate (CAGR), from $171K to $424K.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.